
Biotechnology • Pharmaceuticals • Science
MindMed is a company that specializes in developing innovative treatments for brain health disorders. It utilizes rigorous scientific methods to create a pipeline of product candidates, particularly focusing on the therapeutic potential of psychedelics and other novel compounds. These treatments aim to address unmet patient needs in areas such as Generalized Anxiety Disorder (GAD), Major Depressive Disorder (MDD), and Autism Spectrum Disorder (ASD). MindMed is committed to advancing the research and development of these therapies, although they are not yet approved by the FDA or other health authorities, meaning their safety and efficacy are still under evaluation.
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $30M Post-IPO Equity on 2022-09
November 18

Biotechnology • Pharmaceuticals • Science
MindMed is a company that specializes in developing innovative treatments for brain health disorders. It utilizes rigorous scientific methods to create a pipeline of product candidates, particularly focusing on the therapeutic potential of psychedelics and other novel compounds. These treatments aim to address unmet patient needs in areas such as Generalized Anxiety Disorder (GAD), Major Depressive Disorder (MDD), and Autism Spectrum Disorder (ASD). MindMed is committed to advancing the research and development of these therapies, although they are not yet approved by the FDA or other health authorities, meaning their safety and efficacy are still under evaluation.
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $30M Post-IPO Equity on 2022-09
• Lead portfolio planning and prioritization to align R&D investments with corporate strategy and value creation • Oversee governance processes, including portfolio reviews and decision-making forums • Develop frameworks for scenario planning, risk management, and budget optimization • Build and lead a high-performing program management team responsible for the planning, coordination, and execution of all development programs (preclinical through late-stage) • Ensure cross-functional alignment, transparency, and accountability across clinical, regulatory, CMC, and commercial readiness functions • Oversee integrated project plans, timelines, milestones, and budgets • Interface with key external partners to integrate external project management with our internal cross-functional teams • Establish best practices, tools, and templates for program governance, reporting, and performance tracking • Serve as a key interface between scientific/clinical teams and executive leadership to ensure timely, informed decision-making • Drive continuous improvement and a culture of collaboration, agility, and excellence • Provide regular program and portfolio updates to executive leadership and the Board of Directors • Partner with Finance and Strategy functions on long-range planning and external communications
• Advanced degree in life sciences, medicine, or related field (Ph.D., Pharm.D., or M.S.) strongly preferred • 15+ years of experience in biotechnology or pharmaceutical program and portfolio management, including leadership of late-stage clinical programs • Proven track record in leading cross-functional development teams and managing complex program portfolios • Deep understanding of the drug development process, from IND through NDA and commercialization • Exceptional strategic thinking, analytical, and communication skills • Ability to thrive in a dynamic, fast-growing environment where hands-on leadership is required.
• 100% paid health benefits including Medical, Dental and Vision for you and your dependents • 401(k) program with company match and immediate vesting • Flexible time off • Generous parental leave and some fun fringe perks!
Apply NowNovember 18
Global Vice President leading Strategic Engagements team at Coupa, driving BSM initiatives and maximizing commercial value for clients. Empowering organization through strategic partnerships and C-level engagement.
November 18
Vice President of Biostatistics at Amylyx Pharmaceuticals leading statistical analysis for clinical studies. Overseeing and guiding biostatistics team, ensuring study designs meet regulatory needs.
November 18
Assistant VP/Regional Asset Manager focusing on asset management strategies for affordable housing properties. Overseeing compliance, financials, and property performance across a regional portfolio.
November 18
10,000+ employees
Divisional Vice President leading regional directors at Five Below to ensure flawless execution and drive sales growth. Focus on customer satisfaction, team empowerment, and operational efficiency.
🇺🇸 United States – Remote
💰 $194M Private Equity Round on 2010-10
⏰ Full Time
🔴 Lead
👔 Vice President
🦅 H1B Visa Sponsor
November 18
Vice President of Investor Relations at TTM Technologies, focusing on investor relationships and communications. Engaging with stakeholders to convey TTM's strategic direction and financial performance.